The role of immunotherapy in advanced and recurrent MMR deficient and proficient endometrial carcinoma. Di Dio C, Bogani G, Di Donato V, Cuccu I, et al. Gynecol Oncol 2022;169:27-33.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Di Dio C, Bogani G, Di Donato V, Cuccu I, et al. The role of immunotherapy in advanced and recurrent MMR deficient and proficient endometrial carcinoma. Gynecol Oncol 2022;169:27-33.
PMID: 36493574